News|Videos|June 13, 2023
Transduction for AAV with Sean Hart
Author(s)Chris Spivey
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
3
Onshoring Requires a Plan for Training
4
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
5